443 related articles for article (PubMed ID: 1732120)
1. Factors influencing the eradication of Helicobacter pylori with triple therapy.
Graham DY; Lew GM; Malaty HM; Evans DG; Evans DJ; Klein PD; Alpert LC; Genta RM
Gastroenterology; 1992 Feb; 102(2):493-6. PubMed ID: 1732120
[TBL] [Abstract][Full Text] [Related]
2. Short report: a non-metronidazole triple therapy for eradication of Helicobacter pylori infection--tetracycline, amoxicillin, bismuth.
Graham DY; Lew GM; Ramirez FC; Genta RM; Klein PD; Malaty HM
Aliment Pharmacol Ther; 1993 Feb; 7(1):111-3. PubMed ID: 8439632
[TBL] [Abstract][Full Text] [Related]
3. Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study.
Graham DY; Lew GM; Klein PD; Evans DG; Evans DJ; Saeed ZA; Malaty HM
Ann Intern Med; 1992 May; 116(9):705-8. PubMed ID: 1558340
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
Park KN; Hahm JS; Kim HJ
Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
[TBL] [Abstract][Full Text] [Related]
5. Improved eradication rate of standard triple therapy by adding bismuth and probiotic supplement for Helicobacter pylori treatment in Thailand.
Srinarong C; Siramolpiwat S; Wongcha-um A; Mahachai V; Vilaichone RK
Asian Pac J Cancer Prev; 2014; 15(22):9909-13. PubMed ID: 25520127
[TBL] [Abstract][Full Text] [Related]
6. Triple-drug therapy of Helicobacter pylori infection in duodenal ulcer disease.
Dayal VM; Kumar P; Kamal J; Shahi SK; Agrawal BK
Indian J Gastroenterol; 1997 Apr; 16(2):46-8. PubMed ID: 9114569
[TBL] [Abstract][Full Text] [Related]
7. Comparison of bismuth-containing quadruple and concomitant therapies as a first-line treatment option for Helicobacter pylori.
Kadayifci A; Uygun A; Polat Z; Kantarcioğlu M; Kılcıler G; Başer O; Ozcan A; Emer O
Turk J Gastroenterol; 2012 Feb; 23(1):8-13. PubMed ID: 22505373
[TBL] [Abstract][Full Text] [Related]
8. One-week therapy for Helicobacter pylori. A randomized trial of two treatment regimens.
Scheiman JM; Chey WD; Behler EM; Crause I; Elta GH
J Clin Gastroenterol; 1996 Oct; 23(3):170-3. PubMed ID: 8899495
[TBL] [Abstract][Full Text] [Related]
9. Clarithromycin, tetracycline, and bismuth: a new non-metronidazole therapy for Helicobacter pylori infection.
al-Assi MT; Ramirez FC; Lew GM; Genta RM; Graham DY
Am J Gastroenterol; 1994 Aug; 89(8):1203-5. PubMed ID: 8053435
[TBL] [Abstract][Full Text] [Related]
10. Treatment of Helicobacter pylori reduces the rate of rebleeding in peptic ulcer disease.
Graham DY; Hepps KS; Ramirez FC; Lew GM; Saeed ZA
Scand J Gastroenterol; 1993 Nov; 28(11):939-42. PubMed ID: 8284627
[TBL] [Abstract][Full Text] [Related]
11. Cure of gastric ulcer disease after cure of Helicobacter pylori infection--German Gastric Ulcer Study.
Bayerdörffer E; Miehlke S; Lehn N; Mannes GA; Höchter W; Weingart J; Klann H; Sommer A; Heldwein W; Hatz R; Simon T; Bolle KH; Bästlein E; Meining A; Ruckdeschel G; Stolte M
Eur J Gastroenterol Hepatol; 1996 Apr; 8(4):343-9. PubMed ID: 8781903
[TBL] [Abstract][Full Text] [Related]
12. Twice a day quadruple therapy (bismuth subsalicylate, tetracycline, metronidazole plus lansoprazole) for treatment of Helicobacter pylori infection.
Graham DY; Hoffman J; el-Zimaity HM; Graham DP; Osato M
Aliment Pharmacol Ther; 1997 Oct; 11(5):935-8. PubMed ID: 9354203
[TBL] [Abstract][Full Text] [Related]
13. Omeprazole/amoxicillin versus triple therapy for Helicobacter pylori in duodenal ulcer disease: two-year follow-up of a prospective randomized study.
Labenz J; Stolte M; Peitz U; Tillenburg B; Köhl H; Becker T; Börsch G
Z Gastroenterol; 1995 Oct; 33(10):590-3. PubMed ID: 7502551
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Helicobacter pylori Eradication Rates of 2-Week Levofloxacin-Containing Triple Therapy, Levofloxacin-Containing Bismuth Quadruple Therapy, and Standard Bismuth Quadruple Therapy as a First-Line Regimen.
Kahramanoğlu Aksoy E; Pirinçci Sapmaz F; Göktaş Z; Uzman M; Nazlıgül Y
Med Princ Pract; 2017; 26(6):523-529. PubMed ID: 29131124
[TBL] [Abstract][Full Text] [Related]
15. Randomized comparison of ranitidine bismuth citrate-based triple therapies for Helicobacter pylori.
Laine L; Estrada R; Trujillo M; Emami S
Am J Gastroenterol; 1997 Dec; 92(12):2213-5. PubMed ID: 9399755
[TBL] [Abstract][Full Text] [Related]
16. Short report: short-term triple therapy for H. pylori-associated duodenal ulcer disease.
Patchett S; Beattie S; Keane C; O'Morain C
Aliment Pharmacol Ther; 1992 Feb; 6(1):113-7. PubMed ID: 1543813
[TBL] [Abstract][Full Text] [Related]
17. Helicobacter pylori infection in recurrent abdominal pain in childhood: comparison of diagnostic tests and therapy.
Chong SK; Lou Q; Asnicar MA; Zimmerman SE; Croffie JM; Lee CH; Fitzgerald JF
Pediatrics; 1995 Aug; 96(2 Pt 1):211-5. PubMed ID: 7630671
[TBL] [Abstract][Full Text] [Related]
18. Current Status of Five Different Regimens for Empiric First-Line Helicobacter pylori Eradication in Turkey.
Gungor G; Baglıcakoglu M; Kayacetin E; Biyik M; Ucar R; Goktepe H; Ataseven H; Demir A
Digestion; 2015; 92(2):55-9. PubMed ID: 26183105
[TBL] [Abstract][Full Text] [Related]
19. Helicobacter pylori eradication with doxycycline-metronidazole-bismuth subcitrate triple therapy.
Borody TJ; George LL; Brandl S; Andrews P; Lenne J; Moore-Jones D; Devine M; Walton M
Scand J Gastroenterol; 1992 Apr; 27(4):281-4. PubMed ID: 1589705
[TBL] [Abstract][Full Text] [Related]
20. Seven-Day Bismuth-based Quadruple Therapy as an Initial Treatment for Helicobacter pylori Infection in a High Metronidazole Resistant Area.
Vilaichone RK; Prapitpaiboon H; Gamnarai P; Namtanee J; Wongcha-um A; Chaithongrat S; Mahachai V
Asian Pac J Cancer Prev; 2015; 16(14):6089-92. PubMed ID: 26320500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
